Research Article

Effects of Descurainia sophia on Oxidative Stress Markers and Thirst Alleviation in Hemodialysis Patients: A Randomized Double-Blinded Placebo-Controlled Cross-Over Clinical Trial

Table 2

Effects of DS on oxidative stress markers and thirst alleviation using the coefficient estimation in linear mixed effect carry-over with random intercept and interaction.

EffectEstimateSEDFT value value

Thirst scoreIntercept2.210.065134.95<0.001
D.S. treatment−0.380.111452−3.300.001
Time0.0010.0414520.030.970
Treatmenttime0.120.0814521.590.110

Potassium (mEq/L)Intercept4.390.399611.33<0.001
D.S. treatment>0.010.070.950.030.979
Time−0.030.0795−0.350.727
Carry-over0.230.11962.070.041
Baseline0.1280.05952.510.014

Cholesterol (mg/dl)Intercept83.1416.67984.99<0.001
D.S. treatment−9.194.55952.020.046
Time14.514.59953.160.002
Carry-over0.3626.54980.060.956
Baseline0.0410.057950.760.467

Calcium (mg/dl)Intercept3.150.89963.530.001
D.S. treatment−0.200.29580.700.490
Time0.390.29581.380.172
Carry-over−0.100.3096−0.350.731
Baseline0.560.08587.36<0.001

Triglycerides (mg/dl)Intercept111.1823.77984.68<0.001
D.S. treatment−23.937.82973.060.003
Time−15.827.8197−2.020.056
Carry-over−6.3910.3798−0.620.539
Baseline0.0550.036971.530.129

Sodium (mEq/L)Intercept119.887.949615.10<0.001
D.S. treatment0.111.02690.110.913
Time0.291.04690.280.779
Carry-over3.481.12963.120.002
Baseline0.0750.05691.390.168

Malondialdehyde (μmol/L)Intercept608.21231.21982.630.010
D.S. treatment−316.9981.16933.91<0.001
Time−73.6882.9593−0.0890.377
Carry-over−137.9596.4398−1.430.156
Baseline0.190.06933.220.002

TAC (mmol trolox equiv./L)Intercept2.460.189813.83<0.001
D.S. treatment0.980.0895−12.91<0.001
Time0.030.08950.430.667
Carry-over−0.120.0798−1.720.089
Baseline0.250.05954.61<0.001

DS, Descurainia sophia; SE, standard error; DF, degrees of freedom; TAC, total antioxidant capacity.